Search Within

Yelena Yuriy Janjigian

Formats
  1. Meeting Abstract (217)
  2. Journal Article (156)
  3. Review (11)
  4. Editorial (6)
  5. Book Section (3)
  6. Guidelines (2)
  7. Research Letter (2)
  8. Conference Paper (1)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (400)
  2. Gastrointestinal Oncology Service (400)
  3. Solid Tumor Oncology Division (400)
  4. Center for Pancreatic Cancer Research (161)
  5. Surgery (148)
  6. Department of Pathology and Laboratory Medicine (137)

More Groups

People
  1. David Ilson (112)
  2. Geoffrey Ku (110)
  3. Laura Tang (84)
  4. David Kelsen (74)
  5. Steven Maron (65)
  6. Vivian Strong (65)

More People

Years
  1. 2025 (20)
  2. 2024 (33)
  3. 2023 (42)
  4. 2022 (37)
  5. 2021 (54)
  6. 2020 (23)

More Years

Publications
  1. Journal of Clinical Oncology (146)
  2. Annals of Oncology (44)
  3. Annals of Surgical Oncology (14)
  4. Annals of Surgery (13)
  5. Clinical Cancer Research (13)
  6. Oncology Research and Treatment (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (152)
  2. Oxford University Press (51)
  3. American Association for Cancer Research (28)
  4. Springer (22)
  5. Elsevier Inc. (19)
  6. Elsevier Science, Inc. (17)

More Publishers

Results (400)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival and patterns of failure in oligometastatic esophagogastric cancer
    Meeting Abstract

    Hilal, L.; Ku, G.; Molena, D.; Janjigian, Y.; Ilson, D. H.; Maron, S.; Sihag, S.; Yoon, S. S.; Strong, V.; Crane, C. H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA)
    Meeting Abstract

    Carr, R.; Hsu, M.; Tan, K. S.; Bains, M. S.; Bott, M.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; Park, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I monotherapy dose escalation of RGX-202, a first-in-class oral inhibitor of the SLC6a8/CKB pathway, in patients with advanced gastrointestinal (GI) solid tumors
    Meeting Abstract

    Bendell, J. C.; Strauss, J. F.; Fakih, M.; McRee, A. J.; Hendifar, A. E.; Rosen, L. S.; Cercek, A.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
    Meeting Abstract

    Moehler, M.; Shitara, K.; Garrido, M.; Salman, P.; Shen, L.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Campos Bragagnoli, A.; Liu, T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A phase Ib/II, multicenter, open-label, dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd; DS8201) monotherapy and combinations in patients with HER2-overexpressing gastric cancer (DESTINY-Gastric03)
    Meeting Abstract

    Janjigian, Y. Y.; Viglianti, N.; Liu, F.; Mendoza-Naranjo, A.; Puvvada, S.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Chemotherapy and COVID-19 outcomes in patients with cancer
    Journal Article

    Jee, J.; Foote, M. B.; Lumish, M.; Stonestrom, A. J.; Wills, B.; Narendra, V.; Avutu, V.; Murciano-Goroff, Y. R.; Chan, J. E.; Derkach, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Unique considerations for females undergoing esophagectomy
    Journal Article

    Nobel, T. B.; Livschitz, J.; Eljalby, M.; Janjigian, Y. Y.; Bains, M. S.; Adusumilli, P. S.; Jones, D. R.; Molena, D.
    Annals of Surgery (2020)

    Fulltext@MSK | Save
  • KEYNOTE-859: A randomized, double-blind, placebo-controlled phase 3 trial of first-line pembrolizumab plus chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Tabernero, J.; Bang, Y.; Van Cutsem, E.; Fuchs, C.; Janjigian, Y.; Bhagia, P.; Li, K.; Adelberg, D.; Qin, S.
    Annals of Oncology (2020)

    Fulltext@MSK | Save